(Q48017892)

English

A phase I clinical and pharmacologic study of a carboplatin and irinotecan regimen combined with recombinant human granulocyte-colony stimulating factor in the treatment of patients with advanced nonsmall cell lung carcinoma.

scientific article published in June 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9610696

A phase I clinical and pharmacologic study of a carboplatin and irinotecan regimen combined with recombinant human granulocyte-colony stimulating factor in the treatment of patients with advanced nonsmall cell lung carcinoma. (English)

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9610696

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

H Okamoto

1

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9610696

A Nagatomo

2

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9610696

H Kunitoh

3

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9610696

H Kunikane

4

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9610696

K Watanabe

5

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9610696

language of work or name

0 references

publication date

1 June 1998

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9610696

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9610696

82

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9610696

11

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9610696

2166-2172

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9610696

An early phase II study of CPT-11: a new derivative of camptothecin, for the treatment of leukemia and lymphoma.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980601%2982%3A11%3C2166%3A%3AAID-CNCR11%3E3.0.CO%3B2-S

21 January 2018

Phase II study of CPT-11, a new camptothecin derivative, in metastatic colorectal cancer. CPT-11 Gastrointestinal Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980601%2982%3A11%3C2166%3A%3AAID-CNCR11%3E3.0.CO%3B2-S

21 January 2018

Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980601%2982%3A11%3C2166%3A%3AAID-CNCR11%3E3.0.CO%3B2-S

21 January 2018

Relationships between carboplatin exposure and tumor response and toxicity in patients with ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980601%2982%3A11%3C2166%3A%3AAID-CNCR11%3E3.0.CO%3B2-S

21 January 2018

Carboplatin dosage: prospective evaluation of a simple formula based on renal function

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980601%2982%3A11%3C2166%3A%3AAID-CNCR11%3E3.0.CO%3B2-S

21 January 2018

Establishment and characterization of acquired resistance to platinum anticancer drugs in human ovarian carcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980601%2982%3A11%3C2166%3A%3AAID-CNCR11%3E3.0.CO%3B2-S

21 January 2018

Normalization in the fitting of data by iterative methods. Application to tracer kinetics and enzyme kinetics

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980601%2982%3A11%3C2166%3A%3AAID-CNCR11%3E3.0.CO%3B2-S

21 January 2018

Carboplatin and etoposide pharmacokinetics in patients with testicular teratoma.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980601%2982%3A11%3C2166%3A%3AAID-CNCR11%3E3.0.CO%3B2-S

21 January 2018

Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysis

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980601%2982%3A11%3C2166%3A%3AAID-CNCR11%3E3.0.CO%3B2-S

21 January 2018

Paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a phase II trial

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980601%2982%3A11%3C2166%3A%3AAID-CNCR11%3E3.0.CO%3B2-S

21 January 2018

Relationship between the pharmacokinetics of irinotecan and diarrhea during combination chemotherapy with cisplatin.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980601%2982%3A11%3C2166%3A%3AAID-CNCR11%3E3.0.CO%3B2-S

21 January 2018

Phase I and pharmacologic study of irinotecan and etoposide with recombinant human granulocyte colony-stimulating factor support for advanced lung cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980601%2982%3A11%3C2166%3A%3AAID-CNCR11%3E3.0.CO%3B2-S

21 January 2018

CPT-11: a new derivative of camptothecin for the treatment of refractory or relapsed small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980601%2982%3A11%3C2166%3A%3AAID-CNCR11%3E3.0.CO%3B2-S

21 January 2018

A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980601%2982%3A11%3C2166%3A%3AAID-CNCR11%3E3.0.CO%3B2-S

21 January 2018

CPT-11 in combination with cisplatin for advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980601%2982%3A11%3C2166%3A%3AAID-CNCR11%3E3.0.CO%3B2-S

21 January 2018

Phase I study of irinotecan and cisplatin with granulocyte colony-stimulating factor support for advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980601%2982%3A11%3C2166%3A%3AAID-CNCR11%3E3.0.CO%3B2-S

21 January 2018

Dose-toxicity relationship of carboplatin in combination with cyclophosphamide in ovarian cancer patients

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980601%2982%3A11%3C2166%3A%3AAID-CNCR11%3E3.0.CO%3B2-S

21 January 2018

Effects of carboplatin in combination with other anticancer agents on human leukemia cell lines

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980601%2982%3A11%3C2166%3A%3AAID-CNCR11%3E3.0.CO%3B2-S

21 January 2018

Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980601%2982%3A11%3C2166%3A%3AAID-CNCR11%3E3.0.CO%3B2-S

21 January 2018

Irinotecan (CPT-11) high-dose escalation using intensive high-dose loperamide to control diarrhea

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980601%2982%3A11%3C2166%3A%3AAID-CNCR11%3E3.0.CO%3B2-S

21 January 2018

Analysis of platinum in biological materials by flameless atomic absorption spectrophotometry

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980601%2982%3A11%3C2166%3A%3AAID-CNCR11%3E3.0.CO%3B2-S

21 January 2018

Assessment of Pharmacokinetic Constants from Postinfusion Blood Curves Obtained after I.V. Infusion

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980601%2982%3A11%3C2166%3A%3AAID-CNCR11%3E3.0.CO%3B2-S

21 January 2018

Phase I and pharmacologic studies of the camptothecin analog irinotecan administered every 3 weeks in cancer patients

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980601%2982%3A11%3C2166%3A%3AAID-CNCR11%3E3.0.CO%3B2-S

21 January 2018

Identifiers

10.1002/(SICI)1097-0142(19980601)82:11<2166::AID-CNCR11>3.0.CO;2-S

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9610696

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9610696

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48017892&oldid=1568139683"